Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients

Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients
Conditions: Non-Small Cell Lung Cancer; Radiation-Induced Cardiac Disease

Interventions: Diagnostic Test: Serum Pro-N-Cadherin Biomarker Assessment; Diagnostic Test: Echocardiogram

Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID)

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments